Malin Corporation

Malin Corporation EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Malin Corporation (MLC.IR) as of Oct 12, 2026 is -13.26. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -8.50 — a change of 56.00% (lower).

EV/EBIT

-13.26

YoY

56.00%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Malin Corporation is 2024 -13.26 . EV/EBIT (Enterprise Value to EBIT) of Malin Corporation was 2023 -8.50 . It decreases by 56.00% lower compared to the previous year.

The Malin Corporation EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-2.37 EUR
Jan 1, 2020
-3.72 EUR
Jan 1, 2021
-12.75 EUR
Jan 1, 2022
-47.36 EUR
Jan 1, 2023
-8.50 EUR
Jan 1, 2024
-13.26 EUR
Jan 1, 2025 (e)
-48.21 EUR
Jan 1, 2026 (e)
-43.83 EUR
The Malin Corporation EV/EBIT history
YEAREV/EBITYoY
est-43.83-9.09%
est-48.21+263.57%
-13.26+56.00%
-8.50-82.05%
-47.36+271.43%
-12.75+242.31%
-3.72+57.30%
-2.37+66.43%
-1.42+94.42%
-0.73+2.65%
-0.71-41.94%
-1.23—
Access this data via the Eulerpool API

Malin Corporation Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Malin Corporation's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Malin Corporation's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Malin Corporation's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Malin Corporation grows earnings faster than its peers.

Malin Corporation Stock analysis

What does Malin Corporation do? Malin Corporation PLC is an Irish company that was founded in 2014. The company is a subsidiary of Elan, a company specialized in pharmaceutical development. Malin has focused its business model on identifying, supporting, and scaling startup companies. The company supports and invests in startups in the biopharmaceutical industry that focus on new and innovative therapies. Malin offers help and advice to its portfolio companies in product development and business organization. The company has invested in various areas of the biopharmaceutical industry. For example, it has supported YumaTherapeutics, a company focused on the discovery and development of novel therapeutics for infectious diseases. Malin has also provided financial support to Seres Therapeutics, which has built a pipeline of therapeutics targeting the microbiome, the collection of microorganisms living in the gut. Malin has invested in Inivata, a company specialized in the development of cancer diagnostics. Furthermore, Malin has various other companies in its investment pipeline that deal with a variety of therapeutic possibilities. This includes therapies for genetic diseases and inherited metabolic disorders, as well as applications of gene therapy and immunotherapy. Malin Corporation PLC has also developed its own products and partnerships. One of these partnerships is with Novaerus, another Irish company specialized in the development of air purification systems. Novaerus systems use a plasma-based ion system to destroy bacteria, viruses, and fungi in the air, thus preventing infections. Malin is also involved in research collaborations. One collaboration is with University College Dublin, where Malin provides financial support for research on biopharmaceutical processes. The history of Malin Corporation PLC is characterized by a strong commitment to supporting innovative companies in the biopharmaceutical industry. The company aims to promote the growth and development of startups, offering not only financial support but also advice and expertise. Malin has diversified its investments in various areas of the biopharmaceutical industry and focuses on promoting products that improve people's health and well-being. The company has also developed its own products and partnerships to bring new technologies and therapies to the market. Overall, Malin Corporation PLC is a company specialized in supporting and promoting startups in the biopharmaceutical industry. The company is committed to developing products and therapies that have the potential to improve and prolong people's lives. Malin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Malin Corporation stock

EV/EBIT (Enterprise Value to EBIT) of Malin Corporation is -13.26 in 2024.

EV/EBIT (Enterprise Value to EBIT) of Malin Corporation changed from -8.50 to -13.26, representing a 56.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Malin Corporation since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Malin Corporation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Malin Corporation

All Key Metrics — Malin Corporation